Flow Cytometry Market Research Report: Information By Product & service (Reagents, Consumables), By Technology (Cell-Based Flow Cytometry), By Application (Research Applications, Immunology), By End-User (Research Institutes, Commercial) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Global Flow Cytometry Market Overview

Flow Cytometry Market Size was valued at USD 2.8 billion in 2022. The flow cytometry market industry is projected to grow from USD 3.03 Billion in 2023 to USD 4.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.20% during the forecast period (2022 - 2030).Increase adoption of flow cytometry in stem cell research, rising applications of flow cytometry in clinical research, and growing incidences of HIV & cancer are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Flow Cytometry Market Trends

• Adoption of flow cytometry techniques in clinical research is propelling the market growth

During the drug discovery and development procedures, flow cytometry—an analytical method used in the detection and analysis of physical features of cells or particles—has emerged as a crucial tool for safety and exploratory purposes. Its emergence as a crucial tool is mainly due to technology's ability to quickly examine a large number of particles and produce statistically reliable information on the cell population. Additionally, its multi-parametric approach is aiding flow cytometry's adoption in the processes of drug discovery and development. To address the rising disease burden, a growing number of clinical research are being conducted. Additionally, it is backed by the funding that is readily available for numerous clinical trial initiatives. For instance, in Sept. 2018, for a grant of $18 million over four years for 12 new clinical trials, the U.S. FDA was authorized. The goal of these clinical trials is to create products for people with rare disorders (including primary sclerosing cholangitis, cushing disease, stargardt disease, acute myeloid leukemia, and graft versus host disease, among others). Thus, driving the flow cytometry market revenue.

Also, the factor propelling the market growth is rising adoption of flow cytometry in stem cell research and the growing applications of flow cytometry in clinical research is anticipated to support the market growth for the forecasted period. For instance, in Oct. 2021, In collaboration with Christian Medical College in Vellore, BD Life Sciences-Biosciences inaugurated its second Center of Excellence (CoE) in flow cytometry for clinical research in India. Also, July 2021, the reimagined digital platform for flow cytometry was introduced by Becton, Dickinson, and Company to enable consumers and their procurement teams a better online shopping experience. The new BD Biosciences marketplace is an online destination for the most in-depth users of flow cytometry because it provides the whole range of BD's research, clinical, and single-cell multi-omic products. Such developments raise interest in flow cytometry, which propels the market CAGR.

Figure 1: Total number of registered clinical trial worldwide 2016-2021 

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Moreover, the development and commercialization of technologically cutting-edge flow cytometry solutions that offer streamlined workflows, ease of use, and faster turnaround times is becoming the focus of major players operating in the market. Especially in developed markets where the adoption rate of technologically cutting-edge products is high, such innovative products are anticipated to have significant demand rise during the projection period. For instance, in March 2022, CellMek SPS, an entirely automated sample preparation system for clinical flow cytometry, was introduced by Beckman Coulter (a Danaher Corporation company) in the United States.

Flow Cytometry Market Segment Insights

Flow Cytometry Technology Insights

The flow cytometry market segmentation, based on Technology, includes Cell-Based Flow Cytometry. The Cell-Based Flow Cytometry segment held the majority share in 2021 contribution to around ~75-80% in respect to the flow cytometry market revenue. This is primarily owing to the rising demand for early diagnosis and growing understanding of the advantages of cell-based assays. The adoption is also anticipated to be fueled in the future by technological developments in cell-based assays, like innovation in software, equipment, algorithms, affinity reagents, and labels.

For instance, in June 2018, The Intellicyt iQue3, the newest product from The Sartorius Group, is intended to enable fully automated processing and analysis for flow cytometry workflows, accelerating the period between collecting samples and coming up with practical solutions. The product, that replaces the iQue Screener PLUS, is a new generation of instrument that provides easier user operation and enhanced process security to provide consistent and reliable results with very little user intervention.

Flow Cytometry Application Insights

The flow cytometry market segmentation, based on application, includes research applications, immunology. The research applications segment dominated the market in 2021 This is due to the rising clinical trial and research for the drug development. Hence, rising application for flow cytometry positively impacts the market growth. The method is used in studies of cell biology and molecular diagnostics to evaluate cell parameters, such as the physical features of cells and the detection of biomarkers by specific antibodies, cell type, cell lineage, and maturation stage. Numerous academic disciplines, including molecular biology, immunology, pathology, plant biology, and marine biology, can benefit from the use of this technique. The segment is anticipated to experience considerable increase during the forecast period due to rising R&D efforts.

Flow Cytometry End-User Insights

 The flow cytometry market data has been bifurcated by End-User into research institutes, commercial. The research institutes segment dominated the market in 2021 due to increased investments by government.

Figure 2: Flow Cytometry Market, by Application, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Flow Cytometry Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Flow Cytometry market accounted for USD 1.28 billion in 2022 and is expected to exhibit a significant CAGR 45.80% growth during the study period. This dominance is a consequence of the extensive use of technically advanced flow cytometry technology, significant healthcare spending, and a solid healthcare infrastructure in the United States. In addition, there is a great need for flow cytometry workflow for research purposes due to the broad research activities of research universities and the presence of well-established pharmaceutical companies. The need for the technology has also increased due to the rising frequency of infectious and chronic disorders, notably the COVID-19 outbreak, for both research and diagnosis.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: Flow Cytometry MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe flow cytometry market accounts for the second-largest market share. The region's attraction as a destination for healthcare is influenced by a number of variables, including its excellent standard of care, strict ethical standards, and simple access to specialists. Aside from these elements, another factor promoting the expansion of the flow cytometry market in Europe is the presence of established significant players in the market. Further, the Germany flow cytometry market held the largest market share, and the United Kingdom flow cytometry market was the fastest growing market in the European region

The Asia-Pacific Flow Cytometry Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to expanding biotechnology and pharmaceutical sectors in developing countries such as India and China. The sector is fueled by the rising prevalence of chronic diseases and the expanding use of cytometry equipment in the area's many applications. Additionally, it is anticipated that continuing developments in the fields of cancer and infectious diseases, such COVID-19, will propel the regional market. Additionally, it is anticipated that over the course of the projected period, intensive research initiatives by regional companies for the advancement or development of novel flow cytometry solutions will promote market expansion in the region. Moreover, China flow cytometry market held the largest market share, and the India flow cytometry market was the fastest growing market in the Asia-Pacific region

Flow Cytometry Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the flow cytometry market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the flow cytometry industry must offer cost-effective products and services to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the flow cytometry industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, flow cytometry industry has provided transparency and reduced disruptions in supply chain. The flow cytometry market major player such as Beckman CoulterInc, Becton Dickinson and Company, Danaher, Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories Inc., Luminex Corporation, Miltenyi Biotec, Sysmex Partec GmbH, Agilent Technologies Inc., and others are working to expand the market demand by investing in research and development activities.

The American multinational medical technology company Becton, Dickinson and Company, also known as BD, produces and markets reagents, instrument systems, and medical devices. In some regions, BD also offers consulting and analytics services. The Becton Dickinson and Company was established in 1897 and its headquarters is in United States. For instance, Aug. 2021, A new benchtop cell analyzer named the BD FACSymphony A1 Cell Analyzer was launched by Becton, Dickinson and Company. The fluorescence-activated cell analyzer is anticipated to provide comprehensive flow cytometry capabilities to labs of all sizes.

Also, Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, United States. The company is a manufacturer and distributor of medical, analytical and scientific equipment. It works in diverse range of product portfolio ranging from Real time PCR, Vanquish Core HPLC System, Ultra-low temperature freezer to various medicines related to COVID Solutions. It is anchored by the current workforce of 10,001+ employees. The company has 425+ subsidiaries and 574+ branches running effectively and efficiently over the world. For instance, in June 2021, Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer which combines acoustic focusing flow cytometry technology with a high-speed camera, was introduced by Thermo Fisher Scientific.

Key Companies in the flow cytometry market includes

• 
  

  Beckman CoulterInc

  
  


• 
  

  Becton Dickinson and Company

  
  


• 
  

  Danaher

  
  


• 
  

  Thermo Fisher Scientific

  
  


• 
  

  Merck KGaA

  
  


• 
  

  Bio-Rad Laboratories Inc.

  
  


• 
  

  Luminex Corporation.

  
  


• 
  

  Miltenyi Biotec

  
  


• 
  

  Sysmex Partec GmbH

  
  


• 
  

  Agilent Technologies Inc. k,

  
  


• 
  

  Others

  
  

Flow Cytometry Industry Developments

Oct. 2021: The second Center of Excellence (CoE) in India for flow cytometry clinical research was established by BD Life Sciences-Biosciences in partnership with Christian Medical College in Vellore. Such advances increase the need for flow cytometry, which fuels the market's expansion.

Flow Cytometry Market Segmentation

Flow Cytometry Product & service Outlook

• 
  

  Reagents

  
  


• 
  

  Consumables

  
  

Flow Cytometry Mode of Technology Outlook

• 
  

  Cell-Based Flow Cytometry

  
  

Flow Cytometry Application Outlook

• 
  

  Research Applications

  
  


• 
  

  Immunology

  
  

Flow Cytometry End User Outlook

• 
  

  Research Institutes

  
  


• 
  

  Commercial

  
  

Flow Cytometry Regional Outlook

• 
  

  North America

  
  

• 
  

  US

  
  


• 
  

  Canada

  
  

• 
  

  Europe

  
  

• 
  

  Germany

  
  


• 
  

  France

  
  


• 
  

  UK

  
  


• 
  

  Italy

  
  


• 
  

  Spain

  
  


• 
  

  Rest of Europe

  
  

• 
  

  Asia-Pacific

  
  
  
  
  • 
    

    China

    
    
  
  
  • 
    

    Japan

    
    
  
  
  • 
    

    India

    
    
  
  
  • 
    

    Australia

    
    
  
  
  • 
    

    South Korea

    
    
  
  
  • 
    

    Australia

    
    
  
  
  • 
    

    Rest of Asia-Pacific

    
    
  
  
  
  


• 
  

  Rest of the World

  
  
  
  
  • 
    

    Middle East

    
    
  
  
  • 
    

    Africa

    
    
  
  
  • 
    

    Latin America